Proliferative and chondrogenic potential of mesenchymal stromal cells from pluripotent and bone marrow cells
- PMID: 32959885
- DOI: 10.14670/HH-18-259
Proliferative and chondrogenic potential of mesenchymal stromal cells from pluripotent and bone marrow cells
Abstract
Introduction: Mesenchymal stromal cells (MSCs) can be derived from a wide range of fetal and adult sources including pluripotent stem cells (PSCs). The properties of PSC-derived MSCs need to be fully characterized, in order to evaluate the feasibility of their use in clinical applications. PSC-MSC proliferation and differentiation potential in comparison with bone marrow (BM)-MSCs is still under investigation. The objective of this study was to determine the proliferative and chondrogenic capabilities of both human induced pluripotent stem cell (hiPSC-) and embryonic stem cell (hESC-) derived MSCs, by comparing them with BM-MSCs.
Methods: MSCs were derived from two hiPSC lines (hiPSC-MSCs), the well characterized Hues9 hESC line (hESC-MSCs) and BM from two healthy donors (BM-MSCs). Proliferation potential was investigated using appropriate culture conditions, with serial passaging, until cells entered into senescence. Differentiation potential to cartilage was examined after in vitro chondrogenic culture conditions.
Results: BM-MSCs revealed a fold expansion of 1.18x10⁵ and 2.3x10⁵ while the two hiPSC-MSC lines and hESC-MSC showed 5.88x10¹⁰, 3.49x10⁸ and 2.88x10⁸, respectively. Under chondrogenic conditions, all MSC lines showed a degree of chondrogenesis. However, when we examined the formed chondrocyte micromasses by histological analysis of the cartilage morphology and immunohistochemistry for the chondrocyte specific markers Sox9 and Collagen II, we observed that PSC-derived MSC lines had formed pink rather than hyaline cartilage, in contrast to BM-MSCs.
Conclusion: In conclusion, MSCs derived from both hESCs and hiPSCs had superior proliferative capacity compared to BM-MSCs, but they were inefficient in their ability to form hyaline cartilage.
Similar articles
-
Comparison of the Chondrogenic Potential of Mesenchymal Stem Cells Derived from Bone Marrow and Umbilical Cord Blood Intended for Cartilage Tissue Engineering.Stem Cell Rev Rep. 2020 Feb;16(1):126-143. doi: 10.1007/s12015-019-09914-2. Stem Cell Rev Rep. 2020. PMID: 31745710
-
Isolation and multilineage differentiation of bone marrow mesenchymal stem cells from abattoir-derived bovine fetuses.BMC Vet Res. 2013 Jul 5;9:133. doi: 10.1186/1746-6148-9-133. BMC Vet Res. 2013. PMID: 23826829 Free PMC article.
-
Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis.Biotechnol Bioeng. 2006 Apr 20;93(6):1152-63. doi: 10.1002/bit.20828. Biotechnol Bioeng. 2006. PMID: 16470881
-
Induced pluripotent stem cells in cartilage tissue engineering: a literature review.Biosci Rep. 2024 May 29;44(5):BSR20232102. doi: 10.1042/BSR20232102. Biosci Rep. 2024. PMID: 38563479 Free PMC article. Review.
-
Pluripotent-derived Mesenchymal Stem/stromal Cells: an Overview of the Derivation Protocol Efficacies and the Differences Among the Derived Cells.Stem Cell Rev Rep. 2022 Jan;18(1):94-125. doi: 10.1007/s12015-021-10258-z. Epub 2021 Sep 20. Stem Cell Rev Rep. 2022. PMID: 34545529 Review.
Cited by
-
Induced pluripotent stem cell-derived mesenchymal stem cells (iMSCs) inhibit M1 macrophage polarization and reduce alveolar bone loss associated with periodontitis.Stem Cell Res Ther. 2025 May 2;16(1):223. doi: 10.1186/s13287-025-04327-0. Stem Cell Res Ther. 2025. PMID: 40317064 Free PMC article.
-
Application of mesenchymal stem cells derived from human pluripotent stem cells in regenerative medicine.World J Stem Cells. 2021 Dec 26;13(12):1826-1844. doi: 10.4252/wjsc.v13.i12.1826. World J Stem Cells. 2021. PMID: 35069985 Free PMC article. Review.
-
PSC-MSC-Derived Exosomes Protect against Kidney Fibrosis In Vivo and In Vitro through the SIRT6/β-Catenin Signaling Pathway.Int J Stem Cells. 2021 Aug 30;14(3):310-319. doi: 10.15283/ijsc20184. Int J Stem Cells. 2021. PMID: 34158415 Free PMC article.
-
Integration of Transcriptome and MicroRNA Profile Analysis of iMSCs Defines Their Rejuvenated State and Conveys Them into a Novel Resource for Cell Therapy in Osteoarthritis.Cells. 2023 Jun 30;12(13):1756. doi: 10.3390/cells12131756. Cells. 2023. PMID: 37443790 Free PMC article.
-
Alterations of Glycosphingolipid Glycans and Chondrogenic Markers during Differentiation of Human Induced Pluripotent Stem Cells into Chondrocytes.Biomolecules. 2020 Dec 1;10(12):1622. doi: 10.3390/biom10121622. Biomolecules. 2020. PMID: 33271874 Free PMC article.
References
-
- Centeno C.J., Schultz J.R., Cheever M., Freeman M., Faulkner S., Robinson B. and Hanson R. (2011). Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr. Stem Cell Res. Ther. 6, 368-378. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials